Table 1.
Characteristics of all subjects.
| Eosinophilic Asthma (EA) | Non-eosinophilic Asthma (NEA) | Healthy Control (HC) | |
|---|---|---|---|
| Subjects Number | 13 | 16 | 15 |
| Gender (female/male) | 5/8 | 9/7 | 6/9 |
| Age/years † | 38.38 (33.00, 44.00) | 40.75 (35.25, 47.5) | 38.47 (31.5, 44.5) |
| BMI/(kg·m -2 ) † | 24.09 (21.06, 26.21) | 25.53 (21.56, 28.60) | 22.99 (20.72, 25.81) |
| Serum IgE/(ng·mL -1 ) † | 212.7 (134.9, 275.8)∗∗# | 102.6 (55.77, 132.1) | 106.7 (76.00, 121.9) |
| ACQ6 †§ | 0.9677 (0.67, 1.00) | 1.074 (0.67, 1.35) | NA |
| FEV1/FVC (%) † | 61.0 (54.0, 68.0)∗∗ | 63.6 (56.8, 70.3)∗∗ | 85.3 (82.5, 88.5) |
| FEV1/FVC (% post) † | 77.8 (74.0, 81.0) | 78.5 (74.3, 83.8) | NA |
| FEV1 Reversibility (mL) † | 333.8 (310.0, 380.0) | 330.3 (285.0, 362.5) | NA |
| FEV1 Reversibility (%) † | 16.8 (14.0, 19.0) | 14.9 (12.8, 16.3) | NA |
| Eosinophil (%) † | 8.5 (6.0, 10.0) ∗∗## | 1.3 (1.0, 2.0) | 2.0 (1.0, 2.3) |
| Neutrophil (%) † | 56.2 (50.0, 59.0)# | 64.8 (59.3, 70.3) | 59.75 (56.5, 64.0) |
| Score1 † | 20.46 (10.95, 19.82)# | 9.47 (8.23, 10.25) | NA |
| Score2 † | 25.70 (11.71, 25.71)# | 6.37 (4.54, 6.26) | NA |
†Data are shown as mean (Q1, Q3). §ACQ6 is the average of ACQ6 scores according to the GINA guidelines (updated in 2016)[15]. ∗P < 0.05 versus healthy control group. ∗∗P < 0.01 versus healthy control group. #P < 0.05 versus noneosinophilic asthma group. ##P < 0.01 versus noneosinophilic asthma group.